Yufu Ye

705 total citations
26 papers, 516 citations indexed

About

Yufu Ye is a scholar working on Hepatology, Surgery and Immunology. According to data from OpenAlex, Yufu Ye has authored 26 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Surgery and 9 papers in Immunology. Recurrent topics in Yufu Ye's work include Organ Transplantation Techniques and Outcomes (6 papers), Hepatitis B Virus Studies (6 papers) and Immunotherapy and Immune Responses (5 papers). Yufu Ye is often cited by papers focused on Organ Transplantation Techniques and Outcomes (6 papers), Hepatitis B Virus Studies (6 papers) and Immunotherapy and Immune Responses (5 papers). Yufu Ye collaborates with scholars based in China, Madagascar and United States. Yufu Ye's co-authors include Shusen Zheng, Haiyang Xie, Lin Zhou, Guo‐Ping Jiang, Lijuan Wang, Xiaoli Xie, Fengyuan Che, Jiawei Yin, Lei Geng and Jun Yu and has published in prestigious journals such as Journal of Hepatology, Transplantation and Cancer Letters.

In The Last Decade

Yufu Ye

26 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufu Ye China 12 155 155 151 136 130 26 516
Marie Jaksch Sweden 12 124 0.8× 134 0.9× 139 0.9× 76 0.6× 112 0.9× 14 545
Sowmya Narayanan United States 13 194 1.3× 235 1.5× 233 1.5× 171 1.3× 104 0.8× 20 668
Aki Kaimori Japan 6 77 0.5× 109 0.7× 88 0.6× 131 1.0× 244 1.9× 6 476
Yanshen Peng China 13 142 0.9× 87 0.6× 221 1.5× 284 2.1× 260 2.0× 21 679
Shuji Nambu Japan 9 121 0.8× 112 0.7× 98 0.6× 143 1.1× 232 1.8× 18 484
Ryan C. Widau United States 10 127 0.8× 214 1.4× 141 0.9× 55 0.4× 99 0.8× 31 468
Mei Liu China 12 46 0.3× 69 0.4× 103 0.7× 89 0.7× 96 0.7× 31 387
Yibing Peng United States 14 151 1.0× 352 2.3× 236 1.6× 71 0.5× 58 0.4× 24 642
Amleto Fiocchi Italy 7 36 0.2× 158 1.0× 220 1.5× 249 1.8× 241 1.9× 7 630
Jieyue Liao China 8 63 0.4× 53 0.3× 178 1.2× 61 0.4× 79 0.6× 17 421

Countries citing papers authored by Yufu Ye

Since Specialization
Citations

This map shows the geographic impact of Yufu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufu Ye more than expected).

Fields of papers citing papers by Yufu Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufu Ye. The network helps show where Yufu Ye may publish in the future.

Co-authorship network of co-authors of Yufu Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Yufu Ye. A scholar is included among the top collaborators of Yufu Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufu Ye. Yufu Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoqi, Yu Zhang, Chao Wang, et al.. (2024). Drug-Loaded Biomimetic Carriers for Non-Hodgkin’s Lymphoma Therapy: Advances and Perspective. ACS Biomaterials Science & Engineering. 10(2). 723–742. 2 indexed citations
2.
Xue, Wen, et al.. (2023). Splenectomy for treating hepatosplenic candidiasis: Two cases and literature review suggesting its feasibility. Heliyon. 9(4). e15114–e15114. 1 indexed citations
3.
Zhang, Xuanyu, et al.. (2022). Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohort. Journal of Gastroenterology and Hepatology. 37(6). 1052–1059. 3 indexed citations
4.
Tang, Danting, et al.. (2022). Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?. Frontiers in Oncology. 12. 889034–889034. 12 indexed citations
5.
Cao, Linping, Xi Liu, Yufu Ye, et al.. (2020). Metastatic renal cell carcinoma to the pancreas and subcutaneous tissue 10 years after radical nephrectomy: a case report. Journal of Medical Case Reports. 14(1). 36–36. 5 indexed citations
6.
Tang, Xiaofeng, Weichen Zhang, Yufu Ye, et al.. (2020). LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR‐217 in Hepatic Carcinoma. BioMed Research International. 2020(1). 9515071–9515071. 37 indexed citations
7.
Yin, Jiawei, Xiaoli Xie, Yufu Ye, Lijuan Wang, & Fengyuan Che. (2019). BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases. Bioscience Reports. 39(11). 46 indexed citations
8.
Ye, Yufu, Wei Wang, Weichen Zhang, et al.. (2019). Galectin-1 attenuates hepatic ischemia reperfusion injury in mice. International Immunopharmacology. 77. 105997–105997. 10 indexed citations
9.
Cao, Linping, Lingfeng Zhou, Yufu Ye, et al.. (2019). Selection of treatment for hepatic epithelioid hemangioendothelioma: a single-center experience. World Journal of Surgical Oncology. 17(1). 183–183. 17 indexed citations
10.
Che, Fengyuan, Xiaoli Xie, Long Wang, et al.. (2018). B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas. International Immunopharmacology. 59. 318–327. 32 indexed citations
11.
Ye, Yufu, Junjun Jia, Zhentao Yang, et al.. (2018). Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival. International Immunopharmacology. 65. 470–482. 10 indexed citations
12.
Geng, Lei, Lidong Wang, Tian Shen, et al.. (2018). Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes. Hepatobiliary & pancreatic diseases international. 17(3). 204–209. 10 indexed citations
13.
Zhang, Weichen, Feibo Li, Yufu Ye, et al.. (2017). Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. Transplantation. 101(12). 2862–2872. 12 indexed citations
14.
Geng, Lei, Bingyi Lin, Tian Shen, et al.. (2016). Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative. Hepatobiliary & pancreatic diseases international. 15(3). 316–318. 9 indexed citations
15.
Yu, Jun, Wei Zhang, Yufu Ye, et al.. (2014). Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation. Journal of Hepatology. 61(4). 809–815. 36 indexed citations
16.
Wu, Liming, Lin Chen, Lin Zhou, et al.. (2011). Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population.. PubMed. 11(6). 469–74. 8 indexed citations
17.
Chen, Lin, Yufu Ye, Lin Zhou, et al.. (2011). Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice. Hepatobiliary & pancreatic diseases international. 10(2). 171–178. 16 indexed citations
18.
Ye, Yufu, Lin Zhou, Haiyang Xie, et al.. (2010). Th17 promotes acute rejection following liver transplantation in rats. Journal of Zhejiang University SCIENCE B. 11(11). 819–827. 38 indexed citations
19.
Ye, Yufu, Lin Zhou, Haiyang Xie, et al.. (2010). Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B. Journal of Clinical Immunology. 30(4). 546–555. 74 indexed citations
20.
Ye, Yufu, et al.. (2009). Interaction of B7‐H1 on intrahepatic cholangiocarcinoma cells with PD‐1 on tumor‐infiltrating T cells as a mechanism of immune evasion. Journal of Surgical Oncology. 100(6). 500–504. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026